CULLINAN ONCOLOGY LLC

NASDAQ: CGEM (Cullinan Therapeutics, Inc.)

Last update: 2 hours ago

6.95

-0.04 (-0.57%)

Previous Close 6.99
Open 6.99
Volume 83,929
Avg. Volume (3M) 373,561
Market Cap 410,567,072
Price / Book 0.910
52 Weeks Range
6.61 (-4%) — 18.62 (167%)
Earnings Date 6 Nov 2025
Diluted EPS (TTM) -2.77
Total Debt/Equity (MRQ) 0.33%
Current Ratio (MRQ) 11.62
Operating Cash Flow (TTM) -150.21 M
Levered Free Cash Flow (TTM) -87.13 M
Return on Assets (TTM) -25.38%
Return on Equity (TTM) -36.57%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bearish
Biotechnology (Global) Mixed Bearish
Stock Cullinan Therapeutics, Inc. Bullish Bearish

AIStockmoo Score

1.4
Analyst Consensus 5.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average 1.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
CGEM 411 M - - 0.910
MRNA 10 B - - 1.00
HRMY 2 B - 11.90 2.79
MESO 2 B - - 2.97
ABCL 1 B - - 1.18
CVAC 1 B - 5.39 1.76

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 4.55%
% Held by Institutions 116.27%

Ownership

Name Date Shares Held
Mpm Bioimpact Llc 30 Jun 2025 7,648,268
Lynx1 Capital Management Lp 30 Jun 2025 4,400,842
Blue Owl Capital Holdings Lp 30 Jun 2025 2,385,972
52 Weeks Range
6.61 (-4%) — 18.62 (167%)
Price Target Range
22.00 (216%) — 28.00 (302%)
High 28.00 (Morgan Stanley, 302.88%) Buy
Median 24.00 (245.32%)
Low 22.00 (Stifel, 216.55%) Buy
Average 24.67 (254.96%)
Total 3 Buy
Avg. Price @ Call 8.20
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 21 Aug 2025 24.00 (245.32%) Buy 7.67
Morgan Stanley 18 Aug 2025 28.00 (302.88%) Buy 7.95
Stifel 11 Jun 2025 22.00 (216.55%) Buy 8.98

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria